关于激素治疗的五项研究

2015-09-05 sunshine 译 MedSci原创

近日,Endocrine Today 列出了一些关于激素治疗作用的研究。睾酮注射剂而非睾酮凝胶可增加心血管疾病的发生风险据发表于JAMA Internal Medicine的一项研究表明,与睾酮凝胶相比,睾酮注射剂可增加心血管疾病发生、患者住院及死亡的风险。睾酮贴剂及睾酮凝胶之间同样发现了类似的情况。睾酮治疗可改善性腺机能减退的中老年男性的体重及代谢情况据发表于Clinical Endocri

近日,Endocrine Today 列出了一些关于激素治疗作用的研究。

1.睾酮注射剂而非睾酮凝胶可增加心血管疾病的发生风险

据发表于JAMA Internal Medicine的一项研究表明,与睾酮凝胶相比,睾酮注射剂可增加心血管疾病发生、患者住院及死亡的风险。睾酮贴剂及睾酮凝胶之间同样发现了类似的情况。

2.睾酮治疗可改善性腺机能减退的中老年男性的体重及代谢情况

据发表于Clinical Endocrinology的一项研究表明,性腺机能减退的中老年男性接受睾酮治疗后可减轻其体重并改善其HbA1c、血糖、血压及血脂的水平。

在一项观察性研究中,研究人员比较了连续11年接受睾酮治疗的男性与曾一度中断治疗后又接受睾酮治疗的男性。结果发现,睾酮治疗一旦中断,患者的代谢情况立即恶化,而恢复睾酮治疗后,患者的代谢情况又可好转。

3.生长激素可降低老年女性骨质疏松性骨折的发生风险

据发表于Clinical Endocrinology & Metabolism的一项研究表明,骨质疏松的老年女性接受生长激素治疗后可降低其骨折的发生风险并改善其骨密度,即使是在停药数年后仍可保持此效果。

在一项随机双盲安慰剂对照试验中,研究人员发现,与接受18个月安慰剂注射治疗的女性相比,接受36个月生长激素注射治疗的女性骨质疏松性骨折的发生率可降低50%。

4.每日低剂量的hGG注射治疗与阴道凝胶治疗的妊娠成功率类似

据发表于Human Reproduction的一项研究表明,胚胎植入后连续两周每日皮下注射人绒毛膜促性腺激素的孕妇妊娠的成功率与接受阴道激素凝胶治疗的妊娠成功率相同。

在作为三组随机对照试验的一项验证概念的研究中,研究人员将女性随机分配接受为期两周的每日人绒毛膜促性腺激素注射治疗。结果发现,与每日接受阴道凝胶治疗(可刺激生殖器,凝胶也可渗漏)的女性相比,接受人绒毛膜促性腺激素注射治疗的女性变得更加友善。

5.睾酮治疗并不能治愈男性射精功能障碍

据最近发表于Clinical Endocrinology & Metabolism的一项研究表明,睾酮替代疗法并不能改善射精障碍男性的性功能及其睾酮水平。

“该研究为检验射精障碍治疗方法的第一个临床试验研究,射精障碍的现象比较普遍但是对其了解却知之甚少,严重影响男性的身体健康及其人际关系的交往,” Darius A. Paduch博士说道,“虽然本研究的参与者经睾酮替代疗法治疗后并没有改善其射精功能,但是我们希望我们的工作能带动更多的临床试验以找到该病的治疗方法。”

原始出处:

Five effects of hormone therapy. Healio, September 4, 2015.

J. Bradley Layton et al.Comparative Safety of Testosterone Dosage Forms.JAMA Intern Med. 2015;175(7):1187-1196. doi:10.1001/jamainternmed.2015.1573.

Margaret E. Wierman et al.Risks of Different Testosterone Preparations Too Much, Too Little, Just Right.JAMA Intern Med. 2015;175(7):1197-1198. doi:10.1001/jamainternmed.2015.1580.

Aksam Yassin et al.Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle aged and elderly men.Clin Endocrinol. 2015;doi:10.1111/cen.12936.

Krantz E, et al.Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study. J Clin Endocrinol Metab. 2015;doi:10.1210/jc.2015-1757.

Andersen CY et al.Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.Hum Reprod.2015;doi: 10.1093/humrep/dev184

Paduch DA, et al.Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled TrialJ Clin Endocrinol Metab. 2015;doi:10.1210/jc.2014-4434.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]
    2015-12-27 忠诚向上

    内容丰富

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=49445, encodeId=7e79494458a, content=内容丰富, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 17:53:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41240, encodeId=56444124087, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41241, encodeId=d22841241d3, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41242, encodeId=98d3412427d, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41243, encodeId=9cfe412430f, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 22:54:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307343, encodeId=7ca8130e34311, content=<a href='/topic/show?id=b1d766836e4' target=_blank style='color:#2F92EE;'>#激素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66836, encryptionId=b1d766836e4, topicName=激素治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfa6343, createdName=aliceclz, createdTime=Mon Sep 07 04:30:00 CST 2015, time=2015-09-07, status=1, ipAttribution=)]

相关资讯

乳腺癌激素治疗可能影响认知功能

旧金山——美国临床肿瘤学学会主办的乳腺癌研讨会上公布的一项入组81例患者的前瞻性研究显示,在校正其他因素后,接受激素治疗的乳腺癌患者出现认知功能下降的风险是未接受治疗的患者的7倍以上。此外,神经心理测试的客观结果支持患者的认知功能障碍主诉。研究者表示,激素治疗可能是认知功能障碍的危险因素,应设计干预研究对该组患者进行重点研究。Hope Rugo医生这项研究加州大学旧金山分校乳腺肿瘤学临床试验项目主

Gastroenterology: 布地奈德有望成为治疗嗜酸细胞性食管炎新药物

       北卡罗来纳大学教堂山分校的Evan S.Dellon博士及其同事报告称,一种可吞服的黏性局部类固醇药物在减少嗜酸细胞性食管炎(EoE)患者嗜酸细胞计数的效果方面 优于喷雾溶液,但嗜酸细胞减少与吞咽困难改善并不相关。文章于5月7日在线发表于《Gastroenterology》。        这项首次比较

Acta Obstet Gynecol Scand:如何防止子宫内膜异位症手术治疗后的复发慢性盆腔疼痛

摘要目的:评估诺孕素+戊酸雌二醇(E2V) 与促性腺激素释放激素类似物(GnRH -a)应用于以腹腔镜诊断和治疗子宫内膜异位症时,减少慢性盆腔疼痛病人的疼痛复发的功效。设计:多中心,前瞻性,随机对照研究。地点:意大利三所大学的妇产科对象:78名子宫内膜异位症合并慢性盆腔疼痛女性接受腹腔镜手术治疗。方法:术后处方:第一组,诺孕素+ E2V 9个月;第二组,每月注射GnRH-a,连续6个月。主要观察指

Neurology:激素治疗降AD风险或取决于应用时机

  美国一项研究表明,激素治疗(HT)与阿尔茨海默病(AD)风险的相关性可能取决于应用时机。论文发表于《神经病学》[Neurology 2012,79(18):1846]杂志。   研究纳入1995~2006年间能提供确切绝经信息和HT应用情况的女性1768名。在随访期间共176例女性发生AD。利用考克斯(Cox)比例风险模型评估HT应用与AD的相关性。   结果为,在绝经5年内,应

走出哮喘激素治疗认知误区

  病例简介   患儿男性,15岁,哮喘反复发作6年。   患儿平时很少使用药物治疗控制哮喘,发作时才至医院接受输液治疗。近期曾因一次重症发作,被送至急诊抢救。   医师查阅该患儿既往门诊病历,可见其曾被多次建议应用吸入性糖皮质激素(ICS)或激素联合长效支气管扩张剂治疗。再三询问后得知,患儿父母认为长期应用激素有多种副作用,可能影响患儿生长发育,故未予患儿长期、规律的激素治疗,导致